We advise you to exercise VanEck Vectors fundamental analysis to see if markets are presently mispricing the entity. In other words you can harness it to find out if VanEck Vectors Biotech is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. . We found eleven available drivers for VanEck Vectors Biotech ETF which can be compared to its competition. Please use VanEck Vectors One Year Return and Net Asset to make a decision on weather VanEck Vectors Biotech is priced fairly. Use VanEck Vectors to enhance returns of your portfolios. The etf experiences unexpected upward trend. Watch out for market signals. Check odds of VanEck Vectors to be traded at $144.34 in 30 days
VanEck Vectors Company Summary
VanEck Vectors competes with Health Care, Vanguard Health, iShares Nasdaq, SPDR SP, and iShares US. The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index. VanEck Vectors is traded on NASDAQ General Markets in USA.
VanEck Vectors Five Year Return vs Equity Positions Weight
VanEck Vectors Biotech ETF is rated below average in five year return as compared to similar ETFs. It is second largest ETF in equity positions weight as compared to similar ETFs making about 13.37 of Equity Positions Weight per Five Year Return.
|Five Year Return ( % )|
VanEck Vectors Biotech Systematic Risk